Ampio adds two study sites to expand clinical trial with Ampion for COVID-19
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Ampio reports data from clinical trial of inhaled Ampion
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
J&J"s single-dose coronavirus vaccine is 66% effective against COVID-19, raising worries that some variants may lower protection
J&J's shot was more effective among volunteers in the US than in Latin America and South Africa, where new strains are circulating. A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccin.....»»
Novavax’s Covid-19 vaccine nearly 90% effective in U.K. study, much less in South Africa
Novavax Inc. said Thursday its Covid-19 vaccine candidate was found to be 89.3% effective based on interim data from its clinical trial in the United Kingdom — where a new variant of the virus originated. The results make Novavax’s candidate, called NV.....»»
Ampio completes Phase 1 trial of Ampion in COVID-19, initiates Phase 2
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead Sciences reports positive data in trial of remdesivir as treatment for COVID-19
Gilead Sciences Inc. said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate study......»»
Gilead"s stock halted, says remdesivir met primary endpoint in government study
Gilead Sciences Inc. said Wednesday morning that a government-run clinical trial evaluating its experimental drug remdesivir in certain COVID-19 patie.....»»
Novartis to conduct hydroxychloroquine trial for hospitalized COVID-19 patients
Novartis said it will proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease. The trial will be of approximately 440 patients at more than a dozen sites in the U.....»»
Incyte, Novartis launch drug study to treat coronavirus complication
Incyte Corp. said Friday it and Novartis AG started a late-stage clinical trial to study a drug meant to treat a serious complication of COVID-19. The biotech company said it was testin.....»»
NextCure says COVID-19 put "significant strain" on clinical trial sites
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ampio suspends patient enrollment in Phase 3 clinical trial of Ampion
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ampio announces progress in SPA Phase 3 clinical trial for Ampion
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA says Ampio to complete additional trial under SPA for Ampion study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
RedHill Biopharma to expand opaganib global Phase 2/3 COVID-19 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novavax completes enrollment in Phase 3 clinical trial for its COVID-19 vaccine candidate
Shares of Novavax Inc. were down 6.2% in trading on Monday after the company said it had completed enrollment of the P.....»»
Immunic announces IMU-838 study shows clinical activity in COVID-19 patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead, Galapagos drug fails in Phase 3 clinical study
Shares of Gilead Sciences Inc. were down 0.1% in premarket trading on Thursday, the day after the company said an experimental idiopathic pulmonary fibrosis drug it was developing with Galapagos failed a Phase 3 clinical trial. Shares o.....»»
Ampio reports promising early data from COVID drug trial, Fox Denver says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Corvus begins Phase 3 clinical trial of CPI-006 for COVID-19 patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Publix adds Nassau County to list of Covid vaccination sites
Appointments can be made starting at 6 a.m. Wednesday for Publix locations in 23 Florida counties......»»
J&J CEO: Expect Phase 3 results for its COVID-19 vaccine candidate early next week
Johnson & Johnson expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate "early next week,.....»»